cemiplimab-rwlc
Restricted to use by oncology in the outpatient infusion setting.
Reviewed: August 2019
Updated: May 2021 (HVCC deferred, improved reimbursement)
Restricted to use by oncology in the outpatient infusion setting.
Reviewed: August 2019
Updated: May 2021 (HVCC deferred, improved reimbursement)